Genetic Markers and Front Line FCR/BR Vs. Rve, Gve and Give Treatment - Outcome Results from the CLL13/GAIA Trial

Eugen Tausch; Christof Schneider; Moritz Furstenau; Sandra Robrecht; Deyan Yordanov Yosifov; Daniel Mertens; Michael Gregor; Patrick Thornton; Philipp B. Staber; Tamar Tadmor; Mark-David Levin; Caspar da Cunha-Bang; Christian Bjørn Poulsen; Thomas Illmer; Björn Schöttker; Ann Janssens; Ilse Christiansen; Thomas Noesslinger; Michael Baumann; Clemens-Martin Wendtner; Eric Eldering; Karl-Anton Kreuzer; Matthias Ritgen; Anna-Maria Fink; Kirsten Fischer; Arnon P. Kater; Carsten Utoft Niemann; Michael Hallek; Barbara Eichhorst; Stephan Stilgenbauer

doi:10.1182/blood-2022-163775

Genetic Markers and Front Line FCR/BR Vs. Rve, Gve and Give Treatment - Outcome Results from the CLL13/GAIA Trial

Eugen Tausch, Christof Schneider, Moritz Furstenau, Sandra Robrecht, Deyan Yordanov Yosifov, Daniel Mertens, Michael Gregor, Patrick Thornton, Philipp B. Staber, Tamar Tadmor, Mark-David Levin, Caspar da Cunha-Bang, Christian Bjørn Poulsen, Thomas Illmer, Björn Schöttker, Ann Janssens, Ilse Christiansen, Thomas Noesslinger, Michael Baumann, Clemens-Martin WendtnerEric Eldering, Karl-Anton Kreuzer, Matthias Ritgen, Anna-Maria Fink, Kirsten Fischer, Arnon P. Kater, Carsten Utoft Niemann, Michael Hallek, Barbara Eichhorst, Stephan Stilgenbauer

Publikation: Bidrag til tidsskrift › Konferenceabstrakt i tidsskrift › Forskning › peer review

Originalsprog	Engelsk
Artikelnummer	642
Tidsskrift	Blood
Vol/bind	140
Udgave nummer	Suppl. 1
Sider (fra-til)	839–841
Antal sider	3
ISSN	0006-4971
DOI	https://doi.org/10.1182/blood-2022-163775
Status	Udgivet - 15 nov. 2022
Begivenhed	64th ASH Annual Meeting & Exposition - Ernest N. Morial Convention or virtually, New Orleans, USA Varighed: 10 dec. 2022 → 13 dec. 2022

Konference

Konference	64th ASH Annual Meeting & Exposition
Lokation	Ernest N. Morial Convention or virtually
Land/Område	USA
By	New Orleans
Periode	10/12/2022 → 13/12/2022

Bibliografisk note

Abstrakt No. 642

Adgang til dokumentet

10.1182/blood-2022-163775

AUB Link

Søg efter materialet i Aalborg Universitetsbiblioteks søgemaskine

Citationsformater

Tausch, E., Schneider, C., Furstenau, M., Robrecht, S., Yosifov, D. Y., Mertens, D., Gregor, M., Thornton, P., Staber, P. B., Tadmor, T., Levin, M.-D., da Cunha-Bang, C., Poulsen, C. B., Illmer, T., Schöttker, B., Janssens, A., Christiansen, I., Noesslinger, T., Baumann, M., ... Stilgenbauer, S. (2022). Genetic Markers and Front Line FCR/BR Vs. Rve, Gve and Give Treatment - Outcome Results from the CLL13/GAIA Trial. Blood, 140(Suppl. 1), 839–841. Artikel 642. https://doi.org/10.1182/blood-2022-163775

@article{e4f272b13bbd47c3b14187d083c3decd,

title = "Genetic Markers and Front Line FCR/BR Vs. Rve, Gve and Give Treatment - Outcome Results from the CLL13/GAIA Trial",

author = "Eugen Tausch and Christof Schneider and Moritz Furstenau and Sandra Robrecht and Yosifov, {Deyan Yordanov} and Daniel Mertens and Michael Gregor and Patrick Thornton and Staber, {Philipp B.} and Tamar Tadmor and Mark-David Levin and {da Cunha-Bang}, Caspar and Poulsen, {Christian Bj{\o}rn} and Thomas Illmer and Bj{\"o}rn Sch{\"o}ttker and Ann Janssens and Ilse Christiansen and Thomas Noesslinger and Michael Baumann and Clemens-Martin Wendtner and Eric Eldering and Karl-Anton Kreuzer and Matthias Ritgen and Anna-Maria Fink and Kirsten Fischer and Kater, {Arnon P.} and Niemann, {Carsten Utoft} and Michael Hallek and Barbara Eichhorst and Stephan Stilgenbauer",

note = "Abstract No. 642; 64th ASH Annual Meeting & Exposition, ASH 2022 ; Conference date: 10-12-2022 Through 13-12-2022",

year = "2022",

month = nov,

day = "15",

doi = "10.1182/blood-2022-163775",

language = "English",

volume = "140",

pages = "839–841",

journal = "Blood",

issn = "0006-4971",

publisher = "AMER SOC HEMATOLOGY",

number = "Suppl. 1",

}

Tausch, E, Schneider, C, Furstenau, M, Robrecht, S, Yosifov, DY, Mertens, D, Gregor, M, Thornton, P, Staber, PB, Tadmor, T, Levin, M-D, da Cunha-Bang, C, Poulsen, CB, Illmer, T, Schöttker, B, Janssens, A, Christiansen, I, Noesslinger, T, Baumann, M, Wendtner, C-M, Eldering, E, Kreuzer, K-A, Ritgen, M, Fink, A-M, Fischer, K, Kater, AP, Niemann, CU, Hallek, M, Eichhorst, B & Stilgenbauer, S 2022, 'Genetic Markers and Front Line FCR/BR Vs. Rve, Gve and Give Treatment - Outcome Results from the CLL13/GAIA Trial', Blood, bind 140, nr. Suppl. 1, 642, s. 839–841. https://doi.org/10.1182/blood-2022-163775

TY - ABST

T1 - Genetic Markers and Front Line FCR/BR Vs. Rve, Gve and Give Treatment - Outcome Results from the CLL13/GAIA Trial

AU - Tausch, Eugen

AU - Schneider, Christof

AU - Furstenau, Moritz

AU - Robrecht, Sandra

AU - Yosifov, Deyan Yordanov

AU - Mertens, Daniel

AU - Gregor, Michael

AU - Thornton, Patrick

AU - Staber, Philipp B.

AU - Tadmor, Tamar

AU - Levin, Mark-David

AU - da Cunha-Bang, Caspar

AU - Poulsen, Christian Bjørn

AU - Illmer, Thomas

AU - Schöttker, Björn

AU - Janssens, Ann

AU - Christiansen, Ilse

AU - Noesslinger, Thomas

AU - Baumann, Michael

AU - Wendtner, Clemens-Martin

AU - Eldering, Eric

AU - Kreuzer, Karl-Anton

AU - Ritgen, Matthias

AU - Fink, Anna-Maria

AU - Fischer, Kirsten

AU - Kater, Arnon P.

AU - Niemann, Carsten Utoft

AU - Hallek, Michael

AU - Eichhorst, Barbara

AU - Stilgenbauer, Stephan

N1 - Abstract No. 642

PY - 2022/11/15

Y1 - 2022/11/15

U2 - 10.1182/blood-2022-163775

DO - 10.1182/blood-2022-163775

M3 - Conference abstract in journal

SN - 0006-4971

VL - 140

SP - 839

EP - 841

JO - Blood

JF - Blood

IS - Suppl. 1

M1 - 642

T2 - 64th ASH Annual Meeting & Exposition

Y2 - 10 December 2022 through 13 December 2022

ER -